DAVIDE CAMPARI-MILANO NV (CPR.MI) Fundamental Analysis & Valuation

BIT:CPR • NL0015435975

Current stock price

6.242 EUR
+0.05 (+0.87%)
Last:

This CPR.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. CPR.MI Profitability Analysis

1.1 Basic Checks

  • In the past year CPR was profitable.
  • In the past year CPR had a positive cash flow from operations.
  • Each year in the past 5 years CPR has been profitable.
  • CPR had a positive operating cash flow in each of the past 5 years.
CPR.MI Yearly Net Income VS EBIT VS OCF VS FCFCPR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

1.2 Ratios

  • CPR's Return On Assets of 4.27% is fine compared to the rest of the industry. CPR outperforms 66.67% of its industry peers.
  • CPR's Return On Equity of 8.97% is in line compared to the rest of the industry. CPR outperforms 50.00% of its industry peers.
  • The Return On Invested Capital of CPR (6.57%) is better than 63.33% of its industry peers.
  • CPR had an Average Return On Invested Capital over the past 3 years of 6.98%. This is in line with the industry average of 7.69%.
Industry RankSector Rank
ROA 4.27%
ROE 8.97%
ROIC 6.57%
ROA(3y)3.87%
ROA(5y)4.55%
ROE(3y)8.5%
ROE(5y)9.99%
ROIC(3y)6.98%
ROIC(5y)7.33%
CPR.MI Yearly ROA, ROE, ROICCPR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • CPR has a better Profit Margin (11.35%) than 66.67% of its industry peers.
  • In the last couple of years the Profit Margin of CPR has remained more or less at the same level.
  • Looking at the Operating Margin, with a value of 19.74%, CPR is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • CPR's Operating Margin has improved in the last couple of years.
  • The Gross Margin of CPR (60.31%) is better than 83.33% of its industry peers.
  • In the last couple of years the Gross Margin of CPR has remained more or less at the same level.
Industry RankSector Rank
OM 19.74%
PM (TTM) 11.35%
GM 60.31%
OM growth 3Y-1.78%
OM growth 5Y2.87%
PM growth 3Y-2.76%
PM growth 5Y1.37%
GM growth 3Y0.8%
GM growth 5Y0.82%
CPR.MI Yearly Profit, Operating, Gross MarginsCPR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CPR.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CPR is creating some value.
  • CPR has less shares outstanding than it did 1 year ago.
  • CPR has more shares outstanding than it did 5 years ago.
  • CPR has a better debt/assets ratio than last year.
CPR.MI Yearly Shares OutstandingCPR.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
CPR.MI Yearly Total Debt VS Total AssetsCPR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • CPR has an Altman-Z score of 2.64. This is not the best score and indicates that CPR is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.64, CPR is doing good in the industry, outperforming 76.67% of the companies in the same industry.
  • The Debt to FCF ratio of CPR is 6.60, which is on the high side as it means it would take CPR, 6.60 years of fcf income to pay off all of its debts.
  • CPR's Debt to FCF ratio of 6.60 is fine compared to the rest of the industry. CPR outperforms 66.67% of its industry peers.
  • CPR has a Debt/Equity ratio of 0.59. This is a neutral value indicating CPR is somewhat dependend on debt financing.
  • CPR has a better Debt to Equity ratio (0.59) than 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 6.6
Altman-Z 2.64
ROIC/WACC1
WACC6.59%
CPR.MI Yearly LT Debt VS Equity VS FCFCPR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 2.22 indicates that CPR has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.22, CPR is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • A Quick Ratio of 0.96 indicates that CPR may have some problems paying its short term obligations.
  • CPR has a Quick ratio of 0.96. This is in the better half of the industry: CPR outperforms 76.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.22
Quick Ratio 0.96
CPR.MI Yearly Current Assets VS Current LiabilitesCPR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CPR.MI Growth Analysis

3.1 Past

  • CPR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.22%, which is quite impressive.
  • The Earnings Per Share has been growing by 12.04% on average over the past years. This is quite good.
  • CPR shows a decrease in Revenue. In the last year, the revenue decreased by -0.60%.
  • The Revenue has been growing by 11.48% on average over the past years. This is quite good.
EPS 1Y (TTM)66.22%
EPS 3Y-0.59%
EPS 5Y12.04%
EPS Q2Q%1418.89%
Revenue 1Y (TTM)-0.6%
Revenue growth 3Y4.19%
Revenue growth 5Y11.48%
Sales Q2Q%-2.8%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.72% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 3.29% on average over the next years.
EPS Next Y7.18%
EPS Next 2Y9.68%
EPS Next 3Y13.95%
EPS Next 5Y18.72%
Revenue Next Year1.23%
Revenue Next 2Y3.1%
Revenue Next 3Y4.86%
Revenue Next 5Y3.29%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CPR.MI Yearly Revenue VS EstimatesCPR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 0 0 0 0
CPR.MI Yearly EPS VS EstimatesCPR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

2

4. CPR.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 21.52, CPR is valued on the expensive side.
  • 60.00% of the companies in the same industry are cheaper than CPR, based on the Price/Earnings ratio.
  • CPR's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.51.
  • Based on the Price/Forward Earnings ratio of 19.26, the valuation of CPR can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CPR is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of CPR to the average of the S&P500 Index (22.76), we can say CPR is valued inline with the index average.
Industry RankSector Rank
PE 21.52
Fwd PE 19.26
CPR.MI Price Earnings VS Forward Price EarningsCPR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 60.00% of the companies in the same industry are cheaper than CPR, based on the Enterprise Value to EBITDA ratio.
  • CPR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 19.79
EV/EBITDA 12.59
CPR.MI Per share dataCPR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • CPR has a very decent profitability rating, which may justify a higher PE ratio.
  • CPR's earnings are expected to grow with 13.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)3
PEG (5Y)1.79
EPS Next 2Y9.68%
EPS Next 3Y13.95%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. CPR.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.63%, CPR has a reasonable but not impressive dividend return.
  • CPR's Dividend Yield is slightly below the industry average, which is at 2.75.
  • CPR's Dividend Yield is comparable with the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 1.63%

5.2 History

  • The dividend of CPR decreases each year by -0.23%.
Dividend Growth(5Y)-0.23%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 22.52% of the earnings are spent on dividend by CPR. This is a low number and sustainable payout ratio.
DP22.52%
EPS Next 2Y9.68%
EPS Next 3Y13.95%
CPR.MI Yearly Income VS Free CF VS DividendCPR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M
CPR.MI Dividend Payout.CPR.MI Dividend Payout, showing the Payout Ratio.CPR.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CPR.MI Fundamentals: All Metrics, Ratios and Statistics

DAVIDE CAMPARI-MILANO NV

BIT:CPR (4/2/2026, 5:07:17 PM)

6.242

+0.05 (+0.87%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)03-04
Earnings (Next)05-06
Inst Owners21.32%
Inst Owner ChangeN/A
Ins Owners50.85%
Ins Owner ChangeN/A
Market Cap7.69B
Revenue(TTM)3.05B
Net Income(TTM)346.30M
Analysts71.85
Price Target7.24 (15.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.63%
Yearly Dividend0.04
Dividend Growth(5Y)-0.23%
DP22.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.97%
PT rev (3m)2.75%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.56%
EPS NY rev (3m)-0.71%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.36%
Valuation
Industry RankSector Rank
PE 21.52
Fwd PE 19.26
P/S 2.52
P/FCF 19.79
P/OCF 11.18
P/B 1.99
P/tB 19.37
EV/EBITDA 12.59
EPS(TTM)0.29
EY4.65%
EPS(NY)0.32
Fwd EY5.19%
FCF(TTM)0.32
FCFY5.05%
OCF(TTM)0.56
OCFY8.95%
SpS2.48
BVpS3.14
TBVpS0.32
PEG (NY)3
PEG (5Y)1.79
Graham Number4.52
Profitability
Industry RankSector Rank
ROA 4.27%
ROE 8.97%
ROCE 8.89%
ROIC 6.57%
ROICexc 7.34%
ROICexgc 17.16%
OM 19.74%
PM (TTM) 11.35%
GM 60.31%
FCFM 12.73%
ROA(3y)3.87%
ROA(5y)4.55%
ROE(3y)8.5%
ROE(5y)9.99%
ROIC(3y)6.98%
ROIC(5y)7.33%
ROICexc(3y)7.81%
ROICexc(5y)8.35%
ROICexgc(3y)19.64%
ROICexgc(5y)24.18%
ROCE(3y)9.45%
ROCE(5y)9.92%
ROICexgc growth 3Y-14.23%
ROICexgc growth 5Y-7.25%
ROICexc growth 3Y-6.36%
ROICexc growth 5Y1.27%
OM growth 3Y-1.78%
OM growth 5Y2.87%
PM growth 3Y-2.76%
PM growth 5Y1.37%
GM growth 3Y0.8%
GM growth 5Y0.82%
F-Score8
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 6.6
Debt/EBITDA 3.02
Cap/Depr 201.82%
Cap/Sales 9.81%
Interest Coverage 6.43
Cash Conversion 91.62%
Profit Quality 112.13%
Current Ratio 2.22
Quick Ratio 0.96
Altman-Z 2.64
F-Score8
WACC6.59%
ROIC/WACC1
Cap/Depr(3y)282.75%
Cap/Depr(5y)284.75%
Cap/Sales(3y)11.87%
Cap/Sales(5y)11.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.22%
EPS 3Y-0.59%
EPS 5Y12.04%
EPS Q2Q%1418.89%
EPS Next Y7.18%
EPS Next 2Y9.68%
EPS Next 3Y13.95%
EPS Next 5Y18.72%
Revenue 1Y (TTM)-0.6%
Revenue growth 3Y4.19%
Revenue growth 5Y11.48%
Sales Q2Q%-2.8%
Revenue Next Year1.23%
Revenue Next 2Y3.1%
Revenue Next 3Y4.86%
Revenue Next 5Y3.29%
EBIT growth 1Y1.65%
EBIT growth 3Y2.34%
EBIT growth 5Y14.68%
EBIT Next Year26.5%
EBIT Next 3Y15.07%
EBIT Next 5Y19.58%
FCF growth 1Y84.55%
FCF growth 3Y149.17%
FCF growth 5Y15.69%
OCF growth 1Y2.55%
OCF growth 3Y21.81%
OCF growth 5Y20.37%

DAVIDE CAMPARI-MILANO NV / CPR.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DAVIDE CAMPARI-MILANO NV?

ChartMill assigns a fundamental rating of 5 / 10 to CPR.MI.


What is the valuation status for CPR stock?

ChartMill assigns a valuation rating of 3 / 10 to DAVIDE CAMPARI-MILANO NV (CPR.MI). This can be considered as Overvalued.


How profitable is DAVIDE CAMPARI-MILANO NV (CPR.MI) stock?

DAVIDE CAMPARI-MILANO NV (CPR.MI) has a profitability rating of 7 / 10.


What is the valuation of DAVIDE CAMPARI-MILANO NV based on its PE and PB ratios?

The Price/Earnings (PE) ratio for DAVIDE CAMPARI-MILANO NV (CPR.MI) is 21.52 and the Price/Book (PB) ratio is 1.99.


Can you provide the expected EPS growth for CPR stock?

The Earnings per Share (EPS) of DAVIDE CAMPARI-MILANO NV (CPR.MI) is expected to grow by 7.18% in the next year.